Your browser doesn't support javascript.
loading
Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosis.
Hillman, Hannah; Khan, Nabeela; Singhania, Akul; Dubelko, Paige; Soldevila, Ferran; Tippalagama, Rashmi; DeSilva, Aruna D; Gunasena, Bandu; Perera, Judy; Scriba, Thomas J; Ontong, Cynthia; Fisher, Michelle; Luabeya, Angelique; Taplitz, Randy; Seumois, Gregory; Vijayanand, Pandurangan; Hedrick, Catherine C; Peters, Bjoern; Burel, Julie G.
Affiliation
  • Hillman H; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Khan N; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Singhania A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Dubelko P; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Soldevila F; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Tippalagama R; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • DeSilva AD; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Gunasena B; Department of Paraclinical Sciences, Faculty of Medicine, General Sir John Kotelawala Defence University, Colombo, Sri Lanka.
  • Perera J; Medical Unit, National Hospital for Respiratory Diseases, Welisara, Sri Lanka.
  • Scriba TJ; Department of Paraclinical Sciences, Faculty of Medicine, General Sir John Kotelawala Defence University, Colombo, Sri Lanka.
  • Ontong C; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Fisher M; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Luabeya A; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Taplitz R; South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine and Division of Immunology, Department of Pathology, University of Cape Town, Cape Town, South Africa.
  • Seumois G; Department of Medicine, City of Hope National Medical Center, Duarte, CA, United States.
  • Vijayanand P; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Hedrick CC; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, United States.
  • Peters B; Department of Medicine, University of California San Diego, La Jolla, CA, United States.
  • Burel JG; Center for Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, CA, United States.
Front Immunol ; 13: 1087010, 2022.
Article de En | MEDLINE | ID: mdl-36713384
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose / Monocytes Limites: Humans Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tuberculose / Monocytes Limites: Humans Langue: En Journal: Front Immunol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Suisse